TP53 and lung carcinoma: For instance, induction of stably transfected p53 containing a doxycycline-inducible activator in H1299 lung cancer cells reduced TfR1 levels, suggesting that p53 may promote cell cycle arrest by reducing the availability of intracellular iron [27].